BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 16262974)

  • 21. Modeling stroke management: a qualitative review of cost-effectiveness analyses.
    Guilhaume C; Saragoussi D; Cochran J; François C; Toumi M
    Eur J Health Econ; 2010 Aug; 11(4):419-26. PubMed ID: 20238137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke.
    Moodie ML; Carter R; Mihalopoulos C; Thrift AG; Chambers BR; Donnan GA; Dewey HM
    Stroke; 2004 May; 35(5):1041-6. PubMed ID: 15031457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease.
    Roze S; Liens D; Palmer A; Berger W; Tucker D; Renaudin C
    Curr Med Res Opin; 2006 Dec; 22(12):2549-56. PubMed ID: 17166337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): an Australian economic model for stroke.
    Mihalopoulos C; Cadilhac DA; Moodie ML; Dewey HM; Thrift AG; Donnan GA; Carter RC
    Int J Technol Assess Health Care; 2005; 21(4):499-505. PubMed ID: 16262974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of stroke using patient-level data: a critical review of the literature.
    Luengo-Fernandez R; Gray AM; Rothwell PM
    Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.